arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2510.06290q-bio.GNcs.AIcs.LG
收藏

软证据融合图神经网络用于多视图生物图谱中的癌症驱动基因识别

Soft-Evidence Fused Graph Neural Network for Cancer Driver Gene Identification across Multi-View Biological Graphs

The Faculty of Electrical Engineering and Computer Science, Ningbo University, Ningbo, China(电子工程与计算机科学学院,宁波大学,宁波,中国)

Bang Chen, Lijun Guo, Houli Fan, Wentao He, Rong Zhang

AI总结:

针对现有方法忽略网络异质性和冲突信息的问题,提出SEFGNN框架,在决策层利用Dempster-Shafer理论融合多网络证据,并引入软证据平滑模块,在三个癌症数据集上优于现有基线,有效识别癌症驱动基因。

摘要:

识别癌症驱动基因(CDGs)对于理解癌症机制和开发靶向治疗至关重要。图神经网络(GNNs)近年来已被用于通过捕获生物交互网络中的模式来识别CDGs。然而,大多数基于GNN的方法依赖于单一的蛋白质-蛋白质交互(PPI)网络,忽略了来自其他生物网络的互补信息。一些研究通过一致性约束对齐特征来整合多个网络,以学习统一的基因表示用于CDG识别。然而,这种表示级融合通常假设跨网络的基因关系是一致的,这可能忽视网络异质性并引入冲突信息。为解决此问题,我们提出了软证据融合图神经网络(SEFGNN),一种在决策级别跨多个网络进行CDG识别的新框架。SEFGNN不强制特征级一致性,而是将每个生物网络视为独立的证据源,并使用Dempster-Shafer理论(DST)在决策级别进行不确定性感知融合。为减轻DST带来的过度自信风险,我们进一步引入了软证据平滑(SES)模块,该模块在保持判别性能的同时提高排名稳定性。在三个癌症数据集上的实验表明,SEFGNN始终优于最先进的基线方法,并在发现新型CDGs方面展现出强大潜力。

英文摘要:

Identifying cancer driver genes (CDGs) is essential for understanding cancer mechanisms and developing targeted therapies. Graph neural networks (GNNs) have recently been employed to identify CDGs by capturing patterns in biological interaction networks. However, most GNN-based approaches rely on a single protein-protein interaction (PPI) network, ignoring complementary information from other biological networks. Some studies integrate multiple networks by aligning features with consistency constraints to learn unified gene representations for CDG identification. However, such representation-level fusion often assumes congruent gene relationships across networks, which may overlook network heterogeneity and introduce conflicting information. To address this, we propose Soft-Evidence Fusion Graph Neural Network (SEFGNN), a novel framework for CDG identification across multiple networks at the decision level. Instead of enforcing feature-level consistency, SEFGNN treats each biological network as an independent evidence source and performs uncertainty-aware fusion at the decision level using Dempster-Shafer Theory (DST). To alleviate the risk of overconfidence from DST, we further introduce a Soft Evidence Smoothing (SES) module that improves ranking stability while preserving discriminative performance. Experiments on three cancer datasets show that SEFGNN consistently outperforms state-of-the-art baselines and exhibits strong potential in discovering novel CDGs.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑